Literature DB >> 2313275

Serum IgG subclass responses of humans to inactivated and live influenza A vaccines compared to natural infections with influenza A.

M J Hocart1, J S Mackenzie, G A Stewart.   

Abstract

Studies with various viral agents have suggested that a preferential production of IgG subclasses may occur during infection, but limited information has been reported on the IgG isotypes produced during vaccination with live or killed virus preparations. The serum IgG subclass responses to influenza A infection or inoculation with live or killed influenza A vaccines were examined by an enzyme-linked immunosorbent assay, and results were expressed using a 4-parameter logistic model. It was observed that IgG1 was induced by both natural infections and the live virus vaccine depending on the dose given. Inactivated vaccines induced significant titres of IgG1, IgG2, and IgG3 isotypes in vaccinees, again depending upon the amount of virus preparation administered.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2313275     DOI: 10.1002/jmv.1890300203

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

Authors:  D C Powers; E D Kilbourne; B E Johansson
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

2.  Immunoglobulin G subclass levels and antibody responses to the 2009 influenza A (H1N1) monovalent vaccine among human immunodeficiency virus (HIV)-infected and HIV-uninfected adults.

Authors:  N F Crum-Cianflone; G Collins; G Defang; E Iverson; L E Eberly; C Duplessis; J Maguire; A Ganesan; B K Agan; T Lalani; T Whitman; C Brandt; D Faix; P J Blair; T Burgess
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

3.  Flexible label-free quantitative assay for antibodies to influenza virus hemagglutinins.

Authors:  Paul J Carney; Aleksandr S Lipatov; Arnold S Monto; Ruben O Donis; James Stevens
Journal:  Clin Vaccine Immunol       Date:  2010-07-21

4.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

5.  Unusual patterns of IgG avidity in some young children following two doses of the adjuvanted pandemic H1N1 (2009) influenza virus vaccine.

Authors:  Karen K Yam; Jyotsana Gupta; Angela Brewer; David W Scheifele; Scott Halperin; Brian J Ward
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

6.  Kinetics of antibody response to influenza vaccination in renal transplant recipients.

Authors:  Shivaprakash Gangappa; Jens Wrammert; David Wang; Zhu-Nan Li; Justine S Liepkalns; Weiping Cao; Jufu Chen; Min Z Levine; James Stevens; Suryaprakash Sambhara; Beth Begley; Aneesh Mehta; Thomas C Pearson; Rafi Ahmed; Christian P Larsen
Journal:  Transpl Immunol       Date:  2019-01-18       Impact factor: 1.708

7.  Age-Related Changes in Human Peripheral Blood IGH Repertoire Following Vaccination.

Authors:  Yu-Chang Bryan Wu; David Kipling; Deborah K Dunn-Walters
Journal:  Front Immunol       Date:  2012-07-09       Impact factor: 7.561

8.  Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection.

Authors:  Rui-Yuan Cao; Da-Yong Dong; Rui-Ju Liu; Jian-Feng Han; Guang-Chuan Wang; Hui Zhao; Xiao-Feng Li; Yong-Qiang Deng; Shun-Ya Zhu; Xiao-Yu Wang; Fang Lin; Fu-Jun Zhang; Wei Chen; E-De Qin; Cheng-Feng Qin
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

9.  Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011-2012 influenza vaccine season.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Nicholas V Mendez; Ana Marie Landin; Bonnie B Blomberg
Journal:  Immun Ageing       Date:  2013-04-22       Impact factor: 6.400

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.